Showing results (1351-1360 of 1,799) with videos related to

Sort By:
Pageof 180
Mabs|May 24, 2016
A comparison of biophysical characterization techniques in predicting monoclonal antibody stabilityGeetha Thiagarajan, Andrew Semple, Jose K James, et al.
Mabs|May 24, 2016
DNA immunization combined with scFv phage display identifies antagonistic GCGR specific antibodies and reveals new epitopes on the small extracellular loopsBas van der Woning, Gitte De Boeck, Christophe Blanchetot, et al.
Mabs|June 5, 2016
Advanced assessment of the physicochemical characteristics of Remicade® and Inflectra® by sensitive LC/MS techniquesJing Fang, Catalin Doneanu, William R Alley, et al.
Mabs|July 25, 2017
Evolving patterns in a collaboration network of global R&D on monoclonal antibodiesXiangjun Kong, Jian-Bo Wan, Hao Hu, et al.
Mabs|August 9, 2017
Maximizing in vivo target clearance by design of pH-dependent target binding antibodies with altered affinity to FcRnDanlin Yang, Craig Giragossian, Steven Castellano, et al.
Mabs|August 9, 2017
Biosimilarity under stress: A forced degradation study of Remicade® and Remsima™Karthik Pisupati, Alexander Benet, Yuwei Tian, et al.
Mabs|August 31, 2017
Forced degradation of recombinant monoclonal antibodies: A practical guideChristine Nowak, Jason K Cheung, Shara M Dellatore, et al.
Mabs|July 27, 2017
Chaperone proteins as single component reagents to assess antibody nonspecificityRyan L Kelly, James C Geoghegan, Jared Feldman, et al.
Mabs|June 17, 2016
Acid-induced aggregation propensity of nivolumab is dependent on the FcBoning Liu, Huaizu Guo, Jin Xu, et al.
Mabs|September 7, 2017
Capacity limits of asialoglycoprotein receptor-mediated liver targetingCharlotte Bon, Thomas Hofer, Alain Bousquet-Mélou, et al.
Pageof 180